![Michael Manns](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Manns
Directeur/Bestuurslid bij Vakzine Projekt Management GmbH
Actieve functies van Michael Manns
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Vakzine Projekt Management GmbH
![]() Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Directeur/Bestuurslid | 16-11-2009 | - |
Hannover Medical School | Corporate Officer/Principal | 16-11-2009 | - |
Fachhochschule Mainz | Corporate Officer/Principal | 16-11-2009 | - |
Twincore, Zentrum für Experimentelle und Klinische
![]() Twincore, Zentrum für Experimentelle und Klinische Miscellaneous Commercial ServicesCommercial Services Twincore, Zentrum für Experimentelle und Klinische, is a research institute based in Hannover, Germany. Twincore specializes in translational infection research, with a focus on viral infections, respiratory infections, and organ-specific immunity and metabolism research. The German company also conducts pre-clinical and clinical studies on vaccines and antiviral antibodies. Twincore has an international team of over 40 scientists from more than 20 nations, and the private company places a strong emphasis on international collaboration and exchange programs. The company has organized several symposiums and publishes research papers on various topics related to infection research. The company was founded in 2008, and the CEO is Ulrich Kalinke. | Directeur/Bestuurslid | - | - |
Loopbaan van Michael Manns
Eerdere bekende functies van Michael Manns
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
The Scripps Research Institute
![]() The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | 01-01-1988 | 01-01-1988 |
Opleiding van Michael Manns
Freie Universität Berlin | Graduate Degree |
University of Vienna | Doctorate Degree |
Fachhochschule Mainz | Graduate Degree |
Statistieken
Internationaal
Duitsland | 6 |
Oostenrijk | 2 |
Verenigde Staten | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Graduate Degree | 2 |
Sectoraal
Consumer Services | 6 |
Health Technology | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Vakzine Projekt Management GmbH
![]() Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Health Technology |
Twincore, Zentrum für Experimentelle und Klinische
![]() Twincore, Zentrum für Experimentelle und Klinische Miscellaneous Commercial ServicesCommercial Services Twincore, Zentrum für Experimentelle und Klinische, is a research institute based in Hannover, Germany. Twincore specializes in translational infection research, with a focus on viral infections, respiratory infections, and organ-specific immunity and metabolism research. The German company also conducts pre-clinical and clinical studies on vaccines and antiviral antibodies. Twincore has an international team of over 40 scientists from more than 20 nations, and the private company places a strong emphasis on international collaboration and exchange programs. The company has organized several symposiums and publishes research papers on various topics related to infection research. The company was founded in 2008, and the CEO is Ulrich Kalinke. | Commercial Services |
- Beurs
- Insiders
- Michael Manns
- Ervaring